Cassiopea Overview

  • Founded
  • 2013
Founded
  • Status
  • Public
  • Employees
  • 12
Employees
  • Stock Symbol
  • SKIN
Stock Symbol
  • Share Price
  • $49.36
  • (As of Thursday Closing)

Cassiopea General Information

Description

Cassiopea SpA is an Italy based clinical-stage specialty pharmaceutical company. It is focused on developing and commercializing differentiated medical dermatology products. The company's focus is on the topical treatment of acne; Androgenic Alopecia, (or AGA); and genital warts. Its portfolio comprises four unencumbered clinical candidates namely: Winlevi, for the treatment of acne; Breezula, for the topical treatment of AGA; CB-06-02, for the treatment of genital warts; and CB-06-01, for the treatment of acne.

Contact Information

Formerly Known As
Cosmo Dermatos
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Personal Products
Other Industries
Pharmaceuticals
Stock Exchange
SWX
Primary Office
  • Via Cristoforo Colombo, 1
  • 20020 Lainate(Milano)
  • Italy
+39 02 0000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Cassiopea Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$49.36 $49.54 $24.24 - $64.84 $531M 10.8M 8.12K -$1.16

Cassiopea Financials Summary

In Thousands,
USD
TTM 30-Jun-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 471,613 435,033 358,611 326,753
Revenue 0 0 0 0
EBITDA (10,358) (12,241) (14,730) (11,816)
Net Income (11,683) (13,098) (14,935) (15,401)
Total Assets 26,721 17,991 18,920 34,154
Total Debt 13 11,946 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Cassiopea Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Cassiopea‘s full profile, request access.

Request a free trial

Cassiopea Executive Team (1)

Name Title Board Seat Contact Info
Diana Harbort Chief Executive Officer & Board Member
To view Cassiopea’s complete executive team members history, request access »

Cassiopea Board Members (1)

Name Representing Role Since
00000 0000000 Cassiopea Chief Executive Officer & Board Member 000 0000
To view Cassiopea’s complete board members history, request access »

Cassiopea Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cassiopea Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Cassiopea‘s full profile, request access.

Request a free trial